{"slug":"clinicalintelpulse-theaslangroupllc-com-api-clinical-failure-452140","title":"Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed","host":"clinicalintelpulse.theaslangroupllc.com","method":"GET","resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/failure-analysis","category":"other","description":"Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors.","price_listed":0.2,"price_asked":0.2,"state":"answering","state_label":"Answering","checks_7d":1,"answered_7d":1,"latency_ms_median":267,"reported_calls_30d":1,"reported_payers_30d":1,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"badge":"unverified","paid_checks_7d":0,"paid_ok_7d":0,"example_input":{"method":"GET","queryParams":{"condition":"Disease — e.g. \"Alzheimer Disease\" | \"Sepsis\" | \"ALS\" | \"Depression\" | \"NASH\"","lang":"en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)"},"type":"http"},"output_schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"properties":{"condition":{"type":"string"},"lang":{"type":"string"}},"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"errors":{"additionalProperties":{"properties":{"description":{"type":"string"},"example":{"type":"object"}},"required":["description"],"type":"object"},"description":"Documented error responses, keyed by HTTP status code","type":"object"},"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"},"history":[{"day":"2026-10-18","reachable":true,"status":402,"valid_402":true,"asked_usdc":0.2,"price_match":true,"latency_ms":267,"error":null}],"description_full":"Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors.","last_updated":"2026-10-16T02:44:11.691Z","schemes":["exact"]}